Allergy and Immunology · Madison, WI
NPI
1104874361
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1821 S Stoughton Rd
Madison, WI, 53716
Phone (608) 260-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
5,942 services
Medicare patients, 2024
200
Average age 69
Drug cost, 2024
$464K
773 prescriptions
Company payments, 2025
$73.38
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John T Kelly was code J2357 (injection, omalizumab, 5 mg), 3,390 times for 22 patients. In total John T Kelly billed 5,942 services in 28 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 3,390 | 22 | $29.70 | $101K |
| 95004 Test - Miscellaneous | Office | 603 | 29 | $2.10 | $1,268 |
| 96372 Injection Administration | Office | 112 | 30 | $10.27 | $1,150 |
| 99214 Office E&M - Established | Office | 64 | 54 | $86.15 | $5,514 |
| 94010 Pulmonary Function Testing | Office | 60 | 52 | $16.58 | $995 |
| 95117 Treatment - Miscellaneous | Office | 44 | 22 | $7.62 | $335 |
| 99213 Office E&M - Established | Office | 42 | 37 | $49.33 | $2,072 |
| 99204 Office E&M - New | Office | 35 | 35 | $110.43 | $3,865 |
| 95115 Treatment - Miscellaneous | Office | 33 | 12 | $6.40 | $211 |
| 99215 Office E&M - Established | Office | 28 | 26 | $120.85 | $3,384 |
| 95076 Test - Miscellaneous | Office | 19 | 16 | $88.13 | $1,674 |
| 99205 Office E&M - New | Office | 15 | 15 | $149.62 | $2,244 |
| 36415 Venipuncture Blood Collection | Office | 14 | 14 | $8.65 | $121 |
By year: 2022 $166K for 6,432 services; 2023 $162K for 6,072 services; 2024 $181K for 5,942 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 14 | $8.65 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug John T Kelly prescribed most often to Medicare patients was Montelukast Sodium, with 94 prescriptions and refills. In total John T Kelly wrote 773 Medicare prescriptions that cost $464K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 94 | 232 | 30 | $1,574 |
| Fluticasone Propionate Generic | 64 | 150 | 31 | $1,268 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 57 | 87 | 14 | $10K |
| Xolair Omalizumab | 55 | 55 | Under 11 | $121K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 49 | 53 | 31 | $1,465 |
| Ipratropium Bromide Generic | 42 | 79 | 18 | $2,221 |
| Azelastine Hcl Generic | 38 | 65 | 16 | $994 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 34 | 69 | 11 | $17K |
| Arnuity Ellipta Fluticasone Furoate | 30 | 44 | Under 11 | $8,719 |
| Breo Ellipta Fluticasone/Vilanterol | 24 | 38 | Under 11 | $15K |
| Advair Hfa Fluticasone Propion/Salmeterol | 21 | 36 | Under 11 | $9,845 |
| Advair Diskus Fluticasone Propion/Salmeterol | 20 | 22 | Under 11 | $3,836 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 19 | 19 | Under 11 | $11K |
| Ventolin Hfa Albuterol Sulfate | 19 | 20 | 12 | $1,274 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 18 | 43 | Under 11 | $3,204 |
Brand drugs: 423 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John T Kelly $73.38 ($73.38 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $73.38.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $73.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.